Reviva Pharmaceuticals (RVPH) P/E (2018 - 2026)
Reviva Pharmaceuticals (RVPH) P/E from Oct 18, 2018 to Jul 21, 2026. The TTM Reviva Pharmaceuticals (RVPH) P/E is -0.13. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Reviva Pharmaceuticals (RVPH)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.13 | -86.37% |
| 2025 | -0.94 | -52.52% |
| 2024 | -1.98 | -99.20% |
| 2023 | -248.73 | +21.18% |
| 2022 | -205.26 | +47.06% |
| 2021 | -139.58 | -66.95% |
| 2020 | -422.35 | -182.05% |
| 2019 | 514.73 | -71.86% |
| 2018 | 1.83K | N/A |
Comparison Reviva Pharmaceuticals (RVPH) P/E with competitors
Reviva Pharmaceuticals (RVPH) P/E is -0.13.